Featured News & Insights

While rates for Representations and Warranties Insurance (RWI) have remained at industry-all-time lows over the course of 2024, the incidence of claims has remained at similar levels compared to...

The combination of market uncertainty, elevated interest rates, and persistently high valuation multiples can have the effect of extending an investment’s holding period. The average holding period...

According to recent reporting by S&P Global, dry powder (or unused cash reserves in the M&A market) has accumulated at an accelerated rate in 2024, even as the outlook on deal-making was greatly...

As we enter Q3 2024, the M&A outlook remains optimistic. Deal flow has been steady and is picking up compared to the previous year. According to a recent report by Euclid Transactional (one of our...

The number of submissions in the Representations and Warranties marketplace continued to rise in Q2 2024, above the previous quarter. This is consistent with the increase in M&A activity we have seen...

As M&A activity picks up in 2024, the number of Representations and Warranties Insurance (“RWI”) policies placed in the market has increased in tandem. The uptick in activity is driven by the...

GLP-1 receptor agonists, or GLP-1 RAs, are changing the game for people living with Type 2 diabetes and obesity. These powerful medications, such as Ozempic, Trulicity, and Wegovy, not only help...

It is standard practice that stock purchases include language requiring the purchase of D&O tail insurance covering the Seller’s directors and officers. Seller’s counsel may push for the addition of...

At the end of each year, AIG releases a Representations and Warranties claims report. Being one of the earliest insurers in the space, AIG has robust and comprehensive data about claims in the...